C9303 Zolbetuximab-clzb - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Zolbetuximab-clzb

Brand Name:

Vyloy

Strength:

1mg

HCPCS:

C9303

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

CLDN18.2

Oral (Y/N):

No

FDA Approval Year:

2024

FDA Discontinuation Year:

CMS Effective Date:

March 26, 2025

CMS Discontinuation Date:

Status:

In Use